Contact:

DakoCytomation
Sonja Wulff
+1 970 226 2200
sonja.wulff@dakocytomation.com

XY Inc.
Melissa Katsimpalis
+1 970 484 7500
mkatsimp@isispr.com

DAKOCYTOMATION, XY INC. SIGN RECORD DEAL WITH CHINESE DAIRY INDUSTRY

FORT COLLINS—DakoCytomation and XY Inc. have signed a joint deal worth more than $10 million to help improve milk production in China. Under the agreement, DakoCytomation will place 24 sperm sorters with a leader in the Chinese agricultural industry, and XY Inc. will provide the sperm sorting expertise.

DakoCytomation, most widely known for its cancer diagnostics, manufactures cell sorters for use in life sciences research and industry. XY Inc. holds exclusive global rights to intellectual property for sperm sorting by flow cytometry in all non-human mammals, including livestock. The two companies signed a joint deal with GoldCattle Bio. Inc. and China National Animal Breeding Stock Import and Export Corporation.

“We are excited for this new opportunity to expand into the agricultural market and bring new technology to China’s fledgling dairy industry,” said Jes Østergaard, President and CEO of DakoCytomation.

Under the agreement, DakoCytomation’s MoFlo^® High-Speed Cell Sorters will sort X chromosome-bearing sperm from bull semen to produce more female, milk-producing cattle. Also, Mervyn Jacobson, President and CEO of XY Inc., will assist GoldCattle Bio. in improving the genetic quality of the Chinese dairy herd to yield higher per-animal milk production.

“Traditionally, dairy breeders want three outcomes from a pregnancy: female calves for herd replacements, increased milk production and trouble-free heifer calvings,” Jacobson said. “Dairy breeders in China will benefit from XY Inc.’s cutting-edge sex-selection technology that allows producers to maintain greater control over these desired breeding and production outcomes.”

Currently, the average dairy cow in China — home to a third of the world’s human population — produces 20% of the milk produced by a dairy cow in the United States. On average, people in China consume one-tenth the milk products of someone living in the Western world.

###

DakoCytomation A/S, headquartered in Copenhagen, Denmark, is a leading cancer diagnostics company with a focus on personalized medicine. DakoCytomation offers systems solutions for clinical laboratories and life science researchers, providing tests and instruments so that physicians can link diagnostic results to specific therapies and optimize patient care. The privately held company has significant R&D and manufacturing activities in Denmark, UK and USA, with operations in 20 countries, distributors in 50+ countries and more than 1,300 employees. www.dakocytomation.com

XY Inc., a global biotech company headquartered in Fort Collins, Colorado, USA, holds exclusive global rights to intellectual property for sperm sorting by flow cytometry in all non-human mammals. The sperm-sorting technology, one of the world's most promising biotech industries, separates sperm that carry the X chromosome and produce females from sperm that carry the Y chromosome and produce males. www.xyinc.com

This press release does not constitute an offer of any securities for sale. It contains certain forward-looking statements with respect to the positions of both companies in their industries and their plans if combined. These forward-looking statements are based upon managements’ expectations and beliefs concerning future events. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside the control of the companies, which could cause actual results to differ materially from such statements. These uncertainties and other factors include such things as general business conditions; strength of the economy and growth in the biotech industry; changes in the companies’ relationships with customers and suppliers; changes in operating costs; and regulatory uncertainties.